Company intelligence / Profile preview

Tsykura

Ownership: Private
Development stage: Other

Overview

Tsumura is Japan’s leading developer and supplier of prescription Kampo medicines—traditional Japanese herbal formulas standardized for modern medical use. The company has a dominant market share in Japan’s prescription Kampo sector. Its products are used both as primary therapies and as adjuncts to Western pharmaceuticals. Clinical results support efficacy in several chronic conditions where Western drugs may be less effective or have more side effects.

Therapeutic areas: GastroenterologyPulmonologyCardiovascularWomen's Health
Modalities: Herbal medicine (Kampo formulations)Small molecule
Industry: Biotech

Partnerships

No major global pharma partnerships mentioned; focus is on domestic supply chain integration.

Beyond the preview

Go deeper on Tsykura.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tsykura.

Explore the full profile